Lantheus Holdings Divestiture to PharmaLogic Holdings Corp.
Lantheus Holdings has entered into a definitive agreement to sell its contract development and manufacturing organization (CDMO) business and its Springfield, New Jersey manufacturing facility to PharmaLogic. As part of the transaction, the parties will enter into a long-term supply agreement where PharmaLogic's Agilera franchise will manufacture lutetium Lu 177 dotatate for Lantheus.
- Counterparty
- PharmaLogic Holdings Corp.